5dhh

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:48, 23 October 2024) (edit) (undo)
 
(5 intermediate revisions not shown.)
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 5dhh is ON HOLD
+
==The crystal structure of nociceptin/orphanin FQ peptide receptor (NOP) in complex with SB-612111 (PSI Community Target)==
 +
<StructureSection load='5dhh' size='340' side='right'caption='[[5dhh]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[5dhh]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] and [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5DHH OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5DHH FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.004&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DGW:(5S,7S)-7-{[4-(2,6-DICHLOROPHENYL)PIPERIDIN-1-YL]METHYL}-1-METHYL-6,7,8,9-TETRAHYDRO-5H-BENZO[7]ANNULEN-5-OL'>DGW</scene>, <scene name='pdbligand=OLA:OLEIC+ACID'>OLA</scene>, <scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5dhh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5dhh OCA], [https://pdbe.org/5dhh PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5dhh RCSB], [https://www.ebi.ac.uk/pdbsum/5dhh PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5dhh ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/C562_ECOLX C562_ECOLX] Electron-transport protein of unknown function.[https://www.uniprot.org/uniprot/OPRX_HUMAN OPRX_HUMAN] G-protein coupled opioid receptor that functions as a receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin.<ref>PMID:11238602</ref> <ref>PMID:12568343</ref> <ref>PMID:22596163</ref> <ref>PMID:23086955</ref> <ref>PMID:8137918</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Understanding the mechanism by which ligands affect receptor conformational equilibria is key in accelerating membrane protein structural biology. In the case of G protein-coupled receptors (GPCRs), we currently pursue a brute-force approach for identifying ligands that stabilize receptors and facilitate crystallogenesis. The nociceptin/orphanin FQ peptide receptor (NOP) is a member of the opioid receptor subfamily of GPCRs for which many structurally diverse ligands are available for screening. We observed that antagonist potency is correlated with a ligand's ability to induce receptor stability (Tm) and crystallogenesis. Using this screening strategy, we solved two structures of NOP in complex with top candidate ligands SB-612111 and C-35. Docking studies indicate that while potent, stabilizing antagonists strongly favor a single binding orientation, less potent ligands can adopt multiple binding modes, contributing to their low Tm values. These results suggest a mechanism for ligand-aided crystallogenesis whereby potent antagonists stabilize a single ligand-receptor conformational pair.
-
Authors: Miller, R.L., Thompson, A.A., Trapella, C., Guerrini, R., Malfacini, D., Patel, N., Cherezov, V., Calo, G., Katritch, V., Han, G.W., Stevens, R.C., GPCR Network (GPCR)
+
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor.,Miller RL, Thompson AA, Trapella C, Guerrini R, Malfacini D, Patel N, Han GW, Cherezov V, Calo G, Katritch V, Stevens RC Structure. 2015 Oct 24. pii: S0969-2126(15)00407-4. doi:, 10.1016/j.str.2015.07.024. PMID:26526853<ref>PMID:26526853</ref>
-
Description: The crystal structure of nociceptin/orphanin FQ peptide receptor (NOP) in complex with SB-612111
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
[[Category: Unreleased Structures]]
+
</div>
-
[[Category: Calo, G]]
+
<div class="pdbe-citations 5dhh" style="background-color:#fffaf0;"></div>
-
[[Category: Trapella, C]]
+
== References ==
-
[[Category: Stevens, R.C]]
+
<references/>
-
[[Category: Han, G.W]]
+
__TOC__
-
[[Category: Thompson, A.A]]
+
</StructureSection>
-
[[Category: Katritch, V]]
+
[[Category: Escherichia coli]]
-
[[Category: Malfacini, D]]
+
[[Category: Homo sapiens]]
-
[[Category: Patel, N]]
+
[[Category: Large Structures]]
-
[[Category: Miller, R.L]]
+
[[Category: Calo G]]
-
[[Category: Guerrini, R]]
+
[[Category: Cherezov V]]
-
[[Category: Gpcr Network (Gpcr)]]
+
[[Category: Guerrini R]]
-
[[Category: Cherezov, V]]
+
[[Category: Han GW]]
 +
[[Category: Katritch V]]
 +
[[Category: Malfacini D]]
 +
[[Category: Miller RL]]
 +
[[Category: Patel N]]
 +
[[Category: Stevens RC]]
 +
[[Category: Thompson AA]]
 +
[[Category: Trapella C]]

Current revision

The crystal structure of nociceptin/orphanin FQ peptide receptor (NOP) in complex with SB-612111 (PSI Community Target)

PDB ID 5dhh

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools